Albert Lockhart

Albert Lockhart, M.D., MHS


Professor
Medicine
Cancer Focus

Clinical trials in gastric and esophageal cancers

Research Interest

I am the Chief of the Division of Hematology/Oncology and Associate Director for Clinical Science at the Medical University of South Carolina/Hollings Cancer Center (MUSC/HCC). I have been conducting early phase clinical trials for more than 18 years. In that time, I have been the principal investigator for more than 100 phase I/II and III trials. My specific research focuses on pilot as well as phase I/II clinical trials of novel therapeutics applied to my therapeutic areas of interest, gastrointestinal cancers. In treating these cancers, I aim to incorporate novel agents or molecular/genetic based treatment into therapeutic trials in the pursuit of personalized cancer care. I have developed and led multi-institutional clinical trials involving the treatment of GI tumors through national cooperative groups as well as investigator-initiated studies.

Positions and Scientific Appointments

2021-Present: Associate Director of Clinical Science, Hollings Cancer Center, MUSC, Charleston, SC 2021-Present: Chief, Division of Hematology/Oncology, Department of Medicine, MUSC, Charleston, SC 2021-Present: Professor, Department of Medicine, MUSC, Charleston, SC 2021-Present: Member, Hollings Cancer Center 2017-2021: Member, Sylvester Comprehensive Cancer Center 2017-2021: Professor, Department of Medicine, University of Miami Miller School of Medicine, FL 2016-2017: Professor, Department of Medicine, Washington University, St. Louis, MO 2008-2017: Director, Developmental Therapeutics, Siteman Cancer Center, St. Louis, MO 2008-2017: Member, Siteman Cancer Center 2008-2016: Associate Professor, Dept. of Medicine, Washington University, St. Louis, MO 2001-2008: Assistant Professor, Department of Medicine, Vanderbilt Univ. Med. Ctr., Nashville, TN 2001-2008: Member, Vanderbilt, Ingram Cancer Center

Education

MHS
September 2001
Clinical Trials
Duke University, Durham, NC
Fellowship
June 2001
Hematology Oncology
Duke University Medical Center, Durham, NC
Fellowship
June 2001
Clinical Pharmacology
Glaxo-SmithKline, Research Triangle Park, NC
MD
June 1993
Medicine
University of Texas-Southwestern, Dallas, TX
Residency
June 1993
Medicine
Barnes Hospital at Washington University, St. Louis, MO
BA
May 1989
Biology
Rice University, Houston, TX